Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 167

1.

Approach to dose definition to the gross tumor volume for lung cancer with respiratory tumor motion.

Miura H, Masai N, Oh RJ, Shiomi H, Sasaki J, Inoue T.

J Radiat Res. 2013 Jan;54(1):140-5. doi: 10.1093/jrr/rrs054. Epub 2012 Sep 5.

2.

A novel four-dimensional radiotherapy planning strategy from a tumor-tracking beam's eye view.

Li G, Cohen P, Xie H, Low D, Li D, Rimner A.

Phys Med Biol. 2012 Nov 21;57(22):7579-98. doi: 10.1088/0031-9155/57/22/7579. Epub 2012 Oct 26.

PMID:
23103415
3.

Tumor control probability and the utility of 4D vs 3D dose calculations for stereotactic body radiotherapy for lung cancer.

Valdes G, Robinson C, Lee P, Morel D, Low D, Iwamoto KS, Lamb JM.

Med Dosim. 2015 Spring;40(1):64-9. doi: 10.1016/j.meddos.2014.10.002. Epub 2014 Dec 24.

PMID:
25542785
4.

Evaluation of 4D dose to a moving target with Monte Carlo dose calculation in stereotactic body radiotherapy for lung cancer.

Matsugi K, Nakamura M, Miyabe Y, Yamauchi C, Matsuo Y, Mizowaki T, Hiraoka M.

Radiol Phys Technol. 2013 Jan;6(1):233-40. doi: 10.1007/s12194-012-0193-y. Epub 2012 Dec 18.

PMID:
23247576
5.

Dosimetric comparison of stereotactic body radiotherapy using 4D CT and multiphase CT images for treatment planning of lung cancer: evaluation of the impact on daily dose coverage.

Wang L, Hayes S, Paskalev K, Jin L, Buyyounouski MK, Ma CC, Feigenberg S.

Radiother Oncol. 2009 Jun;91(3):314-24. doi: 10.1016/j.radonc.2008.11.018. Epub 2008 Dec 26.

PMID:
19111362
6.

Four-dimensional treatment planning for stereotactic body radiotherapy.

Guckenberger M, Wilbert J, Krieger T, Richter A, Baier K, Meyer J, Flentje M.

Int J Radiat Oncol Biol Phys. 2007 Sep 1;69(1):276-85.

PMID:
17707282
7.

Investigation of four-dimensional (4D) Monte Carlo dose calculation in real-time tumor tracking stereotatic body radiotherapy for lung cancers.

Chan MK, Kwong DL, Ng SC, Tam EK, Tong AS.

Med Phys. 2012 Sep;39(9):5479-87. doi: 10.1118/1.4739249.

PMID:
22957615
8.

Three-dimensional versus four-dimensional dose calculation for volumetric modulated arc therapy of hypofractionated treatments.

Ehrbar S, Lang S, Stieb S, Riesterer O, Stark LS, Guckenberger M, Klöck S.

Z Med Phys. 2016 Mar;26(1):45-53. doi: 10.1016/j.zemedi.2015.06.010. Epub 2015 Jul 14.

9.

[4D-CT-based plan target volume (PTV) definition compared with conventional PTV definition using general margin in radiotherapy for lung cancer].

Ju X, Li M, Zhou Z, Zhang K, Han W, Fu G, Cao Y, Wang L.

Zhonghua Zhong Liu Za Zhi. 2014 Jan;36(1):34-8. Chinese.

PMID:
24685084
10.

Experimental evaluations of the accuracy of 3D and 4D planning in robotic tracking stereotactic body radiotherapy for lung cancers.

Chan MK, Kwong DL, Ng SC, Tong AS, Tam EK.

Med Phys. 2013 Apr;40(4):041712. doi: 10.1118/1.4794505.

PMID:
23556882
11.

Verification of planning target volume settings in volumetric modulated arc therapy for stereotactic body radiation therapy by using in-treatment 4-dimensional cone beam computed tomography.

Takahashi W, Yamashita H, Kida S, Masutani Y, Sakumi A, Ohtomo K, Nakagawa K, Haga A.

Int J Radiat Oncol Biol Phys. 2013 Jul 1;86(3):426-31. doi: 10.1016/j.ijrobp.2013.02.019. Epub 2013 Apr 5.

PMID:
23562767
12.

Dosimetric impact of breathing motion in lung stereotactic body radiotherapy treatment using intensity modulated radiotherapy and volumetric modulated arc therapy [corrected].

Rao M, Wu J, Cao D, Wong T, Mehta V, Shepard D, Ye J.

Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):e251-6. doi: 10.1016/j.ijrobp.2011.12.001. Epub 2012 Feb 24. Erratum in: Int J Radiat Oncol Biol Phys. 2014 Feb 1;88(2):462. Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):859.

PMID:
22365622
13.

Monte Carlo evaluation of tissue heterogeneities corrections in the treatment of head and neck cancer patients using stereotactic radiotherapy.

Pokhrel D, McClinton C, Sood S, Badkul R, Saleh H, Jiang H, Lominska C.

J Appl Clin Med Phys. 2016 Mar 8;17(2):258-270. doi: 10.1120/jacmp.v17i2.6055.

14.

Time-adjusted internal target volume: a novel approach focusing on heterogeneity of tumor motion based on 4-dimensional computed tomography imaging for radiation therapy planning of lung cancer.

Nishibuchi I, Kimura T, Nakashima T, Ochi Y, Takahashi I, Doi Y, Kenjo M, Kaneyasu Y, Ozawa S, Murakami Y, Wadasaki K, Nagata Y.

Int J Radiat Oncol Biol Phys. 2014 Aug 1;89(5):1129-37. doi: 10.1016/j.ijrobp.2014.04.050. Epub 2014 Jul 8.

PMID:
25035218
15.

Clinical introduction of Monte Carlo treatment planning for lung stereotactic body radiotherapy.

Miura H, Masai N, Oh RJ, Shiomi H, Yamada K, Sasaki J, Inoue T.

J Appl Clin Med Phys. 2014 Jan 6;15(1):4202. doi: 10.1120/jacmp.v15i1.4202.

16.

Dose calculations accounting for breathing motion in stereotactic lung radiotherapy based on 4D-CT and the internal target volume.

Admiraal MA, Schuring D, Hurkmans CW.

Radiother Oncol. 2008 Jan;86(1):55-60. Epub 2007 Dec 20.

PMID:
18082905
17.

Stereotactic ablative radiation therapy for subcentimeter lung tumors: clinical, dosimetric, and image guidance considerations.

Louie AV, Senan S, Dahele M, Slotman BJ, Verbakel WF.

Int J Radiat Oncol Biol Phys. 2014 Nov 15;90(4):843-9. doi: 10.1016/j.ijrobp.2014.06.064. Epub 2014 Oct 18.

PMID:
25585783
18.
19.

ITV, mid-ventilation, gating or couch tracking - A comparison of respiratory motion-management techniques based on 4D dose calculations.

Ehrbar S, Jöhl A, Tartas A, Stark LS, Riesterer O, Klöck S, Guckenberger M, Tanadini-Lang S.

Radiother Oncol. 2017 Jul;124(1):80-88. doi: 10.1016/j.radonc.2017.05.016. Epub 2017 Jun 3.

PMID:
28587761
20.

The relative accuracy of 4D dose accumulation for lung radiotherapy using rigid dose projection versus dose recalculation on every breathing phase.

Valdes G, Lee C, Tenn S, Lee P, Robinson C, Iwamoto K, Low D, Lamb JM.

Med Phys. 2017 Mar;44(3):1120-1127. doi: 10.1002/mp.12069.

PMID:
28019649

Supplemental Content

Support Center